104 related articles for article (PubMed ID: 23416028)
21. Sensitivity of a colorectal cancer screening program based on a guaiac test: a population-based study.
Giai J; Exbrayat C; Boussat B; Poncet F; Bureau du Colombier P; Colonna M; Seigneurin A
Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):106-11. PubMed ID: 23896367
[TBL] [Abstract][Full Text] [Related]
22. Factors Related to Non-participation in the Basque Country Colorectal Cancer Screening Programme.
Solís-Ibinagagoitia M; Unanue-Arza S; Díaz-Seoane M; Martínez-Indart L; Lebeña-Maluf A; Idigoras I; Bilbao I; Portillo I
Front Public Health; 2020; 8():604385. PubMed ID: 33363095
[No Abstract] [Full Text] [Related]
23. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
[TBL] [Abstract][Full Text] [Related]
24. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
25. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
26. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.
Deutekom M; van Rossum LG; van Rijn AF; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
Scand J Gastroenterol; 2010 Nov; 45(11):1345-9. PubMed ID: 20560814
[TBL] [Abstract][Full Text] [Related]
27. Impact of a Primary Care intervention on the colorectal cancer early detection programme.
Luque Mellado FJ; Paino Pardal L; Condomines Feliu I; Tora-Rocamora I; Cuadras Rofastes M; Romero Díaz E; Pacheco Ortiz M; Camuñez Bravo JC; Aldea M; Grau Cano J;
Gastroenterol Hepatol; 2019; 42(6):351-361. PubMed ID: 30954319
[TBL] [Abstract][Full Text] [Related]
28. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
29. [Organized colorectal cancer screening].
Rouëssé J; Sancho-Garnier H;
Bull Acad Natl Med; 2014 Feb; 198(2):387-99. PubMed ID: 26263711
[TBL] [Abstract][Full Text] [Related]
30. [Evaluating colorectal cancer screening strategies (immunological test vs biochemical test) in Catalonia, Spain 2008-2010].
García Martínez M; Binefa Rodríguez G; Milà Díaz N; Rodríguez Moranta F; Gonzalo Diego N; Muñoz Sánchez C; Espinàs Piñol JA; Borràs Andrés JM; Moreno Aguado V
Rev Esp Salud Publica; 2011 Dec; 85(6):593-602. PubMed ID: 22249590
[TBL] [Abstract][Full Text] [Related]
31. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study.
Levi Z; Birkenfeld S; Vilkin A; Bar-Chana M; Lifshitz I; Chared M; Maoz E; Niv Y
Int J Cancer; 2011 May; 128(10):2415-24. PubMed ID: 20658527
[TBL] [Abstract][Full Text] [Related]
32. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
33. [Programme of screening for colorrectal cancer in the Valencia community, Spain: results of the first round (2005-2008)].
Málaga López A; Salas Trejo D; Sala Felis T; Ponce Romero M; Goicoechea Sáez M; Andrés Martínez M; Llorens Ivorra C; González Serrano I;
Rev Esp Salud Publica; 2010; 84(6):731-43. PubMed ID: 21327309
[TBL] [Abstract][Full Text] [Related]
34. False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.
Garcia M; Milà N; Binefa G; Borràs JM; Espinàs JA; Moreno V
J Med Screen; 2012 Jun; 19(2):77-82. PubMed ID: 22653571
[TBL] [Abstract][Full Text] [Related]
35. Five-year experience of organized colorectal cancer screening in a Swedish population - increased compliance with age, female gender, and subsequent screening round.
Blom J; Kilpeläinen S; Hultcrantz R; Törnberg S
J Med Screen; 2014 Sep; 21(3):144-50. PubMed ID: 25070434
[TBL] [Abstract][Full Text] [Related]
36. Informed participation in the Valencian Community Colorectal Cancer Screening Programme from a gender perspective.
Molina-Barceló A; Peiró-Pérez R; Vanaclocha M; Vallés G; Guaita L; Salas D
Gac Sanit; 2018; 32(1):72-76. PubMed ID: 27745772
[TBL] [Abstract][Full Text] [Related]
37. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
[TBL] [Abstract][Full Text] [Related]
38. [Results of the Czech National Colorectal Cancer screening programme - faecal occult blood tests].
Seifert B; Májek O; Zavoral M; Král N; Suchánek S; Ngo O; Dušek L
Klin Onkol; 2014; 27 Suppl 2():87-97. PubMed ID: 25494893
[TBL] [Abstract][Full Text] [Related]
39. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
